Dr. Jeffrey J. Gray's lab at Johns Hopkins University focuses on predicting how proteins interact with one another and how their structures can reveal important biological mechanisms. They develop computational tools to model these protein structures, which are crucial for understanding diseases and creating new therapies, particularly in areas like immunology and cancer. Their work also involves designing antibodies to target specific diseases and incorporates modeling carbohydrates that affect protein functions.

Dr. Honggang Cui's lab at Johns Hopkins University focuses on developing innovative drug delivery systems, specifically using self-assembling nanofiber hydrogels to treat malignant brain tumors like glioblastoma. The research aims to enhance the local delivery of anticancer drugs while minimizing side effects, ultimately improving patient survival rates. They are particularly interested in how these hydrogels can effectively release drugs over time and diffuse throughout brain tissue after tumor removal.

Dr. Tza-Huei Jeff Wang's lab focuses on developing cutting-edge diagnostic platforms to quickly identify bacterial infections and their antibiotic susceptibilities. By using advanced techniques like single-cell molecular analysis and microfluidics, the lab aims to provide faster and more accurate diagnoses for serious conditions like bacteremia and gonorrhea. This work is crucial for improving patient outcomes and tackling the growing problem of antibiotic resistance.

Dr. Denis Wirtz's lab at Johns Hopkins University focuses on improving cancer therapies, especially for pancreatic cancer, using advanced engineering techniques. The research centers on enhancing the movement and effectiveness of CAR T cells, which are immune cells engineered to target and destroy cancer. By creating synthetic receptors that boost how quickly these cells can migrate into tumors, the lab aims to increase treatment success rates for solid tumors, which are notoriously challenging to treat.